RTTNews | Dec 23, 2020 06:21AM EST

06:21 Wednesday, December 23, 2020 (RTTNews.com) - OraSure Technologies, Inc. (OSUR) and microbiome laboratory and analytical services announced that its OMNIgeneORAL collection device was included in the FDA Emergency Use Authorization amendment granted to 3B BlackBio Biotech, a supplier and developer for RT-PCR diagnostic assays in India. The EUA amendment will allow 3B BlackBio Biotech's North American distributor, Genophyll Enterprises, to expand saliva COVID-19 PCR-based viral diagnostic testing across the U.S. as well as from their upcoming New Jersey-based laboratory.

OraSure's OMNIgeneORAL saliva collection devices are intended for use by individuals to collect and immediately stabilize saliva specimens suspected of containing SARS-CoV-2 ribonucleic acid at ambient temperature for transport.

Read the original article on RTTNews ( https://www.rttnews.com/3155870/3b-blackbio-to-use-orasure-omnigene-oral-collection-device-for-sars-cov-2-test.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved